Related Experiment Video
Updated: Aug 11, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Ceftriaxone in febrile neutropenia
1Med. Klinik II, Department of Oncology and Palliative Care, Evangelisches Johannes-Krankenhaus, Bielefeld, Germany. Meinolf-Karthaus@Johanneswerk.de
Abstract:
Standard management of febrile neutropenia requires prompt administration of empirical, broad-spectrum antibiotic therapy, since febrile neutropenia is associated with a significant risk of infectious complications and mortality. Risk-assessment models have been developed that differentiate febrile patients with neutropenia according to their risk for infectious complications and/or mortality and have prompted a change in the management of these patients. Ceftriaxone is a long-lasting, broad spectrum cephalosporin which has demonstrated efficacy in this indication in many publications. The role of ceftriaxone in febrile neutropenia will be discussed based on literature analysis and on the author's experience.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Streptococcal Pharyngitis
Inhibitors of Bacterial DNA Synthesis

